Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)

被引：0
|
作者：
Chen, Jinzhang
Zang, Mengya
Pang, Huajin
Li, Chuanjiang
Zhao, Jianbo
Guo, Yabing
Hou, Jinlin
机构：
[1] Southern Med Univ, Hepatol Unit, Nanfang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Dept Infect Dis, Nanfang Hosp, Guangzhou, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, State Key Lab Organ Failure Res,Guangdong Prov Ke, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16128
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Thalidomide plus tegafur/uracil for the treatment of advanced/metastatic hepatocellular carcinoma (HCC): A phase II single-arm study
    Hsu, C.
    Chang, D.
    Lin, Z.
    Lee, K.
    Hsiao, C.
    Shen, Y.
    Cheng, A.
    Hsu, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Efficacy and safety of envafolimab plus lenvatinib combined with TACE in initially unresectable hepatocellular carcinoma: An open-label, single-arm, phase II study
    Bai, Xueli
    Chen, Yiwen
    Zhang, Junlei
    Hu, Wendi
    Li, Xiang
    Shen, Yan
    Zhang, Min
    Wu, Jian
    Gao, Shunliang
    Yu, Jun
    Que, Risheng
    Zhang, Yun
    Yang, Fuchun
    Xia, Weiliang
    Zhang, Aibin
    Tang, Xiaofeng
    Liang, Tingbo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI study): A prospective, single-arm, phase II trial
    Chen, Jing
    Li, Kezhen
    Hu, Yingjie
    Han, Yingyan
    Shen, Yuanming
    Wang, Yanzhou
    Song, Kun
    Xia, Bairong
    Chen, Xiaojun
    Zou, Dongling
    Wang, Yingmei
    Sun, Chaoyang
    Chen, Gang
    Ma, Ding
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [35] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Guozhen Yang
    Xiaodong Su
    Yuanheng Huang
    Guangyu Luo
    Zhiqiang Wang
    Peiqiang Cai
    Yating Zheng
    Ting Bei
    Mengli Huang
    Yuezong Bai
    Haoqiang He
    Jin Xiang
    Muyan Cai
    Jiudi Zhong
    Qiyu Guo
    Xu Zhang
    Journal of Translational Medicine, 21
  • [36] Camrelizumab in combination with apatinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: A prospective, single-arm, phase 2 study
    Cui, Yunlong
    Bao, Xu
    Yu, Ge
    Li, Huikai
    Fang, Feng
    Li, Qiang
    Zhang, Wei
    Wu, Qiang
    Chen, Lu
    Liu, Chen
    Song, Tianqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study
    Jiang, Yi
    Su, Ke
    Li, Han
    Wang, Chenjie
    Wu, Zhenying
    Chen, Jiali
    Zhang, Zhiyao
    He, Kun
    Han, Yunwei
    INVESTIGATIONAL NEW DRUGS, 2025, 43 (01) : 18 - 29
  • [38] Preliminary efficacy and safety of perioperative treatment of camrelizumab combined with apatinib in resectable hepatocellular carcinoma (HCC): A prospective phase II study.
    Xia, Yongxiang
    Wang, Ping
    Pu, Liyong
    Qian, Xiaofeng
    Cheng, Feng
    Wang, Ke
    Zhang, Chuanyong
    Li, Donghua
    Li, Xiangcheng
    Zhang, Feng
    Zhao, Jie
    Li, Si
    Xi, Wenjing
    Wang, Xuehao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] TACE combined with the intra-arterial infusion of sintilimab and bevacizumab for advanced hepatocellular carcinoma: A prospective, single-arm, phase II study
    Mu, Maoyuan
    Fu, Xiaobo
    Qi, Han
    Jiang, Weiwei
    Chen, Zixiong
    Gao, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Adjuvant lenvatinib after radical resection in patients with hepatocellular carcinoma (HCC): Preliminary analysis of a prospective, multi-center, single-arm study.
    Zhou, Jian
    Sun, Hui-Chuan
    Huang, Zhi-Yong
    Liu, Lianxin
    Wen, Tianfu
    Zhu, Xiao-Dong
    Shi, Yinghong
    Gao, Qiang
    Qiu, Shuang-Jian
    Ding, Zhenbin
    Wang, Zheng
    Ye, Qing-Hai
    Huang, Xiao-Wu
    Huang, Cheng
    Peng, Yuan-Fei
    Shi, Guoming
    Wang, Xiao-Ying
    Fan, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16158 - E16158
12345